The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
Open accessAbstract
BACKGROUND: We previously showed that activation of the bile salt nuclear receptor Farnesoid X Receptor (FXR) protects against intestinal inflammation in mice. Reciprocally, these inflammatory mediators may decrease FXR activation. We investigated whether FXR activation is repressed in the ileum and colon of inflammatory bowel disease (IBD) patients in remission. Additionally, we evaluated whether genetic variation in FXR is associated with IBD. METHODS: mRNA expression of FXR and FXR target gene SHP was determined in ileal and colonic biopsies of patients with Crohn's colitis (n = 15) and ulcerative colitis (UC; n = 12), all in clinical remission, and healthy controls (n = 17). Seven common tagging SNPs and two functional SNPs in FXR were genotyped in 2355 Dutch IBD patients (1162 Crohn's disease (CD) and 1193 UC) and in 853 healthy controls. RESULTS: mRNA expression of SHP in the ileum is reduced in patients with Crohn's colitis but not in patients with UC compared to controls. mRNA expression of villus marker Villin was correlated with FXR and SHP in healthy controls, a correlation that was weaker in UC patients and absent in CD patients. None of the SNPs was associated with IBD, UC or CD, nor with clinical subgroups of CD. CONCLUSIONS: FXR activation in the ileum is decreased in patients with Crohn's colitis. This may be secondary to altered enterohepatic circulation of bile salts or transrepression by inflammatory signals but does not seem to be caused by the studied SNPs in FXR. Increasing FXR activity by synthetic FXR agonists may have benefit in CD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study evaluating genetic variations in NR1H4 found no association between single-nucleotide polymorphisms in this gene and IBD risk (Nijmeijer et al., 2011).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Nijmeijer et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,551
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J., Gasché, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,410
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Self-citationNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,806
Anderson, C., Boucher, G., Lees, C., Franke, A., D'Amato, M., Taylor, K., Lee, J., Goyette, P., Imieliński, M., Latiano, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.764 · Cited by 1,361
Self-citation
Flagged first, then by citations
1 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Commensal bacteria at the interface of host metabolism and the immune system
Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
Postler, T. S., & Ghosh, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.008 · Cited by 876
“…in the composition of the bile acid pool, an increase in colonic expression of GPBAR1, and a decrease in ileal activity of BAR have all been detected in patients suffering from IBD (Cipriani et al., 2011; Duboc et al., 2013; Lenz et al., 1976; Nijmeijer et al., 2011; Rutgeerts et al., 1979).”
BackgroundFleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 615
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00566-7 · Cited by 490
Molecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481
Emerging roles of bile acids in mucosal immunity and inflammation
Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 305
Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease
Hegyi, P., Maléth, J., Walters, J. R., Hofmann, A. F., & Keely, S. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00054.2017 · Cited by 269
Bile Acid Signaling in Inflammatory Bowel Diseases
Fiorucci, S., Carino, A., Baldoni, M., Santucci, L., Costanzi, E., Graziosi, L., Distrutti, E., & Biagioli, M. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06715-3 · Cited by 243
Pregnane X receptor as a target for treatment of inflammatory bowel disorders
Cheng, J., Shah, Y. M., & Gonzalez, F. J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.003 · Cited by 162
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 160
Labbé, A., Ganopolsky, J. G., Martoni, C., Prakash, S., & Jones, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115175 · Cited by 149
Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J. (2015) · Microorganisms · doi:10.3390/microorganisms3040641 · Cited by 135
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
Hiebl, V., Ladurner, A., Latkolik, S. L., & Dirsch, V. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.003 · Cited by 141
Pavlidis, P., Powell, N., Vincent, R. P., Ehrlich, S. D., Bjarnason, I., & Hayee, B. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13333 · Cited by 135
Gadaleta, R. M., García‐Irigoyen, O., Cariello, M., Scialpi, N., Peres, C., Vetrano, S., Fiorino, G., Danese, S., Ko, B., Luo, J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102719 · Cited by 126
Self-citationBile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 128
Microbial Metabolites, Postbiotics, and Intestinal Epithelial Function
Mayorgas, A., Dotti, I., & Salas, A. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000188 · Cited by 130
Davison, J. M., Lickwar, C. R., Song, L., Breton, G., Crawford, G. E., & Rawls, J. F. (2017) · Genome Research · doi:10.1101/gr.220111.116 · Cited by 114
Tissue-specific actions of FXR in metabolism and cancer
Gadaleta, R. M., Cariello, M., Sabbà, C., & Moschetta, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.005 · Cited by 112
Self-citationRenga, B., Mencarelli, A., Cipriani, S., D’Amore, C., Carino, A., Bruno, A. M., Francisci, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054472 · Cited by 106
Bile acids activated receptors in inflammatory bowel disease
Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S. (2021) · Cells · doi:10.3390/cells10061281 · Cited by 103
Bile Acid Malabsorption in Inflammatory Bowel Disease
Vı́tek, L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000193 · Cited by 105
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
Cariello, M., Piccinin, E., García‐Irigoyen, O., Sabbà, C., & Moschetta, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.019 · Cited by 102
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease
Wilson, A. S., Teft, W. A., Morse, B. L., Choi, Y., Woolsey, S., DeGorter, M. K., Hegele, R. A., Tirona, R. G., & Kim, R. B. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3797-3 · Cited by 97
Huang, X., Zhao, W., & Huang, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.117 · Cited by 98
Vaughn, B. P., Kaiser, T., Staley, C. M., Hamilton, M. J., Reich, J., Graiziger, C. T., Singroy, S., Kabage, A. J., Sadowsky, M. J., & Khoruts, A. (2019) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s186097 · Cited by 95
Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
Jahnel, J., Fickert, P., Hauer, A. C., Högenauer, C., Avian, A., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058065 · Cited by 92
Western Diet Deregulates Bile Acid Homeostasis, Cell Proliferation, and Tumorigenesis in Colon
Đermadi, D., Valo, S., Ollila, S., Soliymani, R., Sipari, N., Pussila, M., Sarantaus, L., Lindén, J., Baumann, M., & Nyström, M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2860 · Cited by 91
Immunology of bile acids regulated receptors
Fiorucci, S., Marchianò, S., Urbani, G., Giorgio, C. D., Distrutti, E., Zampella, A., & Biagioli, M. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101291 · Cited by 88
Anderson, K. M., & Gayer, C. P. (2021) · Cells · doi:10.3390/cells10113206 · Cited by 82
Stojančević, M., Stankov, K., & Mikov, M. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/538452 · Cited by 77
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
Wilson, A. S., Almousa, A. A., Teft, W. A., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-58644-w · Cited by 75
Role of bile acids in inflammatory bowel disease
Tiratterra, E. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0239 · Cited by 73
FXR mediates ILC-intrinsic responses to intestinal inflammation
Fu, T., Li, Y., Oh, T. G., Cayabyab, F., He, N., Tang, Q., Coulter, S., Truitt, M., Medina, P., He, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213041119 · Cited by 68
Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD
Klepsch, V., Moschen, A. R., Tilg, H., Baier, G., & Hermann‐Kleiter, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01070 · Cited by 63
Visschers, R. G. J., Luyer, M. D., Schaap, F. G., Olde Damink, S. W. M., & Soeters, P. B. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32836410a4 · Cited by 60
The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease
Suau, R., Pardina, E., Domènech, E., Lorén, V., & Manyé, J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab159 · Cited by 60
Attinkara, R., Mwinyi, J., Truninger, K., Reguła, J., Gaj, P., Rogler, G., Kullak-Ublick, G. A., Eloranta, J. J., & The Swiss IBD Cohort Study Group (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-461 · Cited by 56
Merk, D., Lamers, C., Ahmad, K. A., Gomez, R. C., Schneider, G., Steinhilber, D., & Schubert‐Zsilavecz, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500937v · Cited by 55
Torres, J., Bao, X., Iuga, A. C., Chen, A., Harpaz, N., Ullman, T. A., Cohen, B. L., de Chambrun, G. P., Asciutti, S., Odin, J. A., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286ff2e · Cited by 54
Dong, X., Qi, M., Cai, C., Zhu, Y., Li, Y., Coulter, S., Sun, F., Liddle, C., Uboha, N. V., Halberg, R. B., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170428 · Cited by 47
Jamieson, P. E., Carbonero, F. G., & Stevens, J. F. (2023) · Current Research in Food Science · doi:10.1016/j.crfs.2023.100521 · Cited by 49
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD
Astorga, J., Gasaly, N., Dubois‐Camacho, K., la Fuente, M. D., Landskron, G., Faber, K. N., Urra, F. A., & Hermoso, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028953 · Cited by 43
Bile Acid Malabsorption Deactivates Pregnane X Receptor in Patients with Crohn’s Disease
Iwamoto, J., Saito, Y., Honda, A., Miyazaki, T., Ikegami, T., & Matsuzaki, Y. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f423 · Cited by 40
Attia, Y. M., Tawfiq, R. A., Gibriel, A. A., Ali, A. A., Kassem, D. H., Hammam, O. A., & Elmazar, M. M. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114497 · Cited by 39
Bretto, E., Caviglia, G. P., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2025) · Biomedicines · doi:10.3390/biomedicines13081807 · Cited by 41
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion
Hucke, S., Herold, M. V. B., Liebmann, M., Freise, N., Lindner, M., Fleck, A.-K., Zenker, S., Thiebes, S., Fernández‐Orth, J., Buck, D., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1593-6 · Cited by 39
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Merk, D., Gabler, M., Gomez, R. C., Flesch, D., Hanke, T., Kaiser, A., Lamers, C., Werz, O., Schneider, G., & Schubert‐Zsilavecz, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.053 · Cited by 35
Bacterial metabolites directly modulate farnesoid X receptor activity
Zhang, X., Osaka, T., & Tsuneda, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0045-y · Cited by 34
Diarrhea in Crohn’s Disease: Investigating the Role of the Ileal Hormone Fibroblast Growth Factor 19
Nolan, J., Johnston, I. M., Pattni, S. S., Dew, T. K., Orchard, T. R., & Walters, J. R. F. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju022 · Cited by 35
Systems Biology Approaches for Inflammatory Bowel Disease
Moco, S., Candela, M., Chuang, E., Draper, C. F., Cominetti, O., Montoliu, I., Barron, D., Kussmann, M., Brigidi, P., Gionchetti, P., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000116 · Cited by 34
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease
van Zutphen, T., Bertolini, A., de Vries, H. D., Bloks, V. W., de Boer, J. F., Jonker, J. W., & Kuipers, F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_233 · Cited by 31
Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease
Valentino, P. L., Feldman, B. M., Walters, T. D., Griffiths, A. M., Ling, S. C., Pullenayegum, E., & Kamath, B. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000558 · Cited by 30
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
Yu, Q., Wu, L., Ji, J., Feng, J., Dai, W., Li, J., Wu, J., & Guo, C. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s277870 · Cited by 27
Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
Ning, L., Lou, X., Zhang, F., & Xu, G. (2019) · Mediators of Inflammation · doi:10.1155/2019/2624941 · Cited by 27
Rau, M., Stieger, B., Monte, M. J., Schmitt, J., Jahn, D., Frey-Wagner, I. M., Raselli, T., Marı́n, J. J. G., Müllhaupt, B., Rogler, G., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000879 · Cited by 26
Crohn’s Disease Is Associated with Decreased CYP3A4 and P‑Glycoprotein Protein Expression
Wilson, A. S., Urquhart, B. L., Ponich, T. P., Chande, N., Gregor, J. C., Beaton, M. D., & Kim, R. B. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00459 · Cited by 26
Li, L., Wang, Y., Zhao, L., Ye, G., Shi, F., Li, Y., Zou, Y., Song, X., Zhao, X., Yin, Z., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115682 · Cited by 25
van Schaik, F. D. M., Gadaleta, R. M., Schaap, F. G., van Mil, S. W. C., Siersema, P. D., Oldenburg, B., & van Erpecum, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049706 · Cited by 25
Self-citationKoutsounas, I. S., Theocharis, S. E., Delladetsima, I. K., Patsouris, E., & Giaginis, C. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.999664 · Cited by 25
The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease
Deuring, J. J., de Haar, C. G., Kuipers, E. J., Peppelenbosch, M. P., & van der Woude, C. J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.12.020 · Cited by 23
Nolan, J., Johnston, I. M., & Walters, J. R. F. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.66 · Cited by 23
Darvin, S. S., Toppo, E., Esakkimuthu, S., Krishna, T. P. A., Ceasar, S. A., Stalin, A., Balakrishna, K., Muniappan, N., Pazhanivel, N., Mahaprabhu, R., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.116 · Cited by 23
Intestinal failure to produce FGF19: A culprit in intestinal failure–associated liver disease?
van Erpecum, K. J., & Schaap, F. G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.012 · Cited by 22
Kumar, A., Al-Hassi, H. O., Steed, H., Phipps, O., & Brookes, M. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/8416578 · Cited by 21
Chen, M., Yang, X., Lai, X., Kang, J., Gan, H., & Gao, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040536 · Cited by 20
Therapeutic Role of Bile Acids and Nuclear Receptor Agonists in Fibrosing Cholangiopathies
Trauner, M., Halilbasic, E., Kazemi-Shirazi, L., Kienbacher, C., Staufer, K., Traussnigg, S., & Hofer, H. (2014) · Digestive Diseases · doi:10.1159/000360517 · Cited by 19
Flesch, D., Gabler, M., Lill, A., Gomez, R. C., Steri, R., Schneider, G., Stark, H., Schubert‐Zsilavecz, M., & Merk, D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.035 · Cited by 19
Honke, N., Shaabani, N., Hardt, C., Krings, C., Häussinger, D., Lang, P. A., Lang, K. S., & Keitel, V. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000456168 · Cited by 18
Nijmeijer, R. M., Schaap, F. G., Smits, A. J. J., Kremer, A. E., Akkermans, L. M. A., Kroese, A. B. A., Rijkers, G. T., Schipper, M. E. I., Verheem, A., Wijmenga, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114393 · Cited by 17
Self-citationMerk, D., Steinhilber, D., & Schubert‐Zsilavecz, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.860129 · Cited by 16
Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
Torres, J., Palmela, C., de Sena, P. G., Santos, M. P. C., Gouveia, C. F., Oliveira, M. H., Henriques, A. R., Rodrigues, C. M. P., Cravo, M. L., & Borralho, P. (2017) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000481197 · Cited by 16
Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells
Girisa, S., Rana, V., Parama, D., Dutta, U., & Kunnumakkara, A. B. (2021) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.02.006 · Cited by 15
Sex differences feed into nuclear receptor signaling along the digestive tract
Dean, A. E., Reichardt, F., & Anakk, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166211 · Cited by 14
Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients
Wilson, A. S., Wang, Q., Almousa, A. A., Jansen, L. E., Choi, Y., Schwarz, U. I., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68686-9 · Cited by 14
Liu, M., Wang, M., Sun, X., Mu, J., Teng, T., Jin, N., Song, J., Li, B., & Zhang, D. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143926 · Cited by 12
Wang, Y., Zheng, L., Zhou, Z., Yao, D., Huang, Y., Liu, B., Duan, Y., & Li, Y. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16676 · Cited by 12
Panek-Jeziorna, M., & Mulak, A. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/2389312 · Cited by 11
Lyutakov, I., Nakov, R., Valkov, H. Y., Vatcheva-Dobrevska, R., Vladimirov, B. G., & Penchev, P. I. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.20247 · Cited by 11
Esworthy, R. S., Kim, B.-W., Wang, Y., Gao, Q., Doroshow, J. H., Leto, T. L., & Chu, F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.013 · Cited by 10
Bile Acids in Control of the Gut-Liver-Axis
Hild, B., Heinzow, H. S., Schmidt, H., & Maschmeier, M. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1330-9644 · Cited by 10
Ten Reasons to Think About Bile Acids in Managing Inflammatory Bowel Disease
Camilleri, M. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa175 · Cited by 9
Li, Y., Xu, T., Zhao, Y., Zhang, H., Liu, Z., Wang, H., Huang, C.-Y., Shu, Z., Gao, L., Xie, R., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02304 · Cited by 9
Xu, Z., Huang, G., Gong, W., Zhao, Y., Zhou, P., Zeng, Y., & He, F. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0008 · Cited by 8
Harrouche, K., Boutaoui, N., Saidi, K. M., Stiti, M. Z., Khellafi, A., & Khelili, S. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500374 · Cited by 7
Yang, J., van Dijk, T. H., Koehorst, M., Havinga, R., de Boer, J. F., Kuipers, F., & van Zutphen, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044132 · Cited by 7
Bariatric surgery attenuates colitis in an obese murine model
Li, S., Vinci, A., Behnsen, J., Cheng, C., Jellbauer, S., Raffatellu, M., Sousa, K. M., Edwards, R. A., Nguyen, N. T., Stamos, M. J., et al. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.10.024 · Cited by 6
Xenobiotic and endobiotic handling by the mucosal immune system
Chen, M. L., & Sundrud, M. S. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000478 · Cited by 6
Ye, W., Bai, X., Zhao, Y., Du, Z., Liu, F., Wang, Y., & Chen, W. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167750 · Cited by 5
Wen, F., Bian, D., Wu, X., Liu, R., Wang, C., & Gan, J. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14021 · Cited by 5
Paraiso, I. L., Magaña, A. A., Alexiev, A., Sharpton, T. J., Maier, C. S., Kioussi, C., & Stevens, J. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331040 · Cited by 4
Ceulemans, L. J., Canovai, E., Verbeke, L., Pirenne, J., & Farré, R. (2016) · Acta chirurgica Belgica · doi:10.1080/00015458.2016.1215953 · Cited by 4
Nuclear Receptors and Lipid Sensing
Thorne, J. L., & Cioccoloni, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_5 · Cited by 3
Role of Bile Acids and Nuclear Receptors in Acupuncture in Improving Crohn’s Disease
Shen, J., Qi, Q., Han, D., Liu, S., Huang, R., Zhu, Y., Zheng, H., Gu, K., Wu, H., & Liu, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5814048 · Cited by 3
Sun, M.-Y., & Lin, J. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.10.006 · Cited by 2
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
Li, F., Chen, Q., Dai, Y., & Lu, L. (2025) · iScience · doi:10.1016/j.isci.2025.114042 · Cited by 1
Mózes, B., Kiss, G., Fóthi, Á., Ferenczi, S., & Psáder, R. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1829399 · Cited by 1
Metadata
- Authors
- Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C. F., Verspaget, H. W., Weersma, R. K., van der Woude, C. J., Stapelbroek, J. M., Schipper, M. E. I., Wijmenga, C., van Erpecum, K. J., Oldenburg, B., & on behalf of the Dutch Initiative on Crohn, C. (.
- Affiliations
- University Medical Center Utrecht (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University Medical Center Groningen (NL)
- Leiden University Medical Center (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Oldenburg, Bas
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-22
- Volume
- 6
- Issue
- 8
- Pages
- e23745
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3161760
- OpenAlex
- W2119543164
- Cited by
- 119
- References
- 35
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 2 · 2022: 11 · 2021: 13 · 2020: 11 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 9 · 2012: 8
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- UvA-DARE (University of Amsterdam) (acceptedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Universiteit Utrecht
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- farnesoid X receptor, FXR activation, inflammatory bowel disease, Crohn's disease, ulcerative colitis, SHP, ileum, villin, genetic variation, single nucleotide polymorphisms, FXR agonists, intestinal inflammation
- MeSH terms
- Receptor, Farnesoid X-Activated, Colitis, Ulcerative, Colon, Female, Humans, Ileum, Male, RNA, Messenger, Genetic Variation, Inflammatory Bowel Diseases, Gene Expression, Case-Control Studies, Receptors, Cytoplasmic and Nuclear, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
